Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Few drugs have generated as much excitement as Novo Nordisk‘s (NYSE: NVO) Ozempic and Wegovy. The U.S. Food and Drug Administration (FDA) approved …
Read MoreFew drugs have generated as much excitement as Novo Nordisk‘s (NYSE: NVO) Ozempic and Wegovy. The U.S. Food and Drug Administration (FDA) approved …
Read MoreIn this video, I will talk about five interesting companies worth your attention. I chose companies in different industries that could provide significant …
Read MoreRequired minimum distributions (RMDs) are mandatory annual distributions the government requires you to take from most retirement accounts beginning in the …
Read MoreBy now, I'm sure you realize that artificial intelligence (AI) is by far the biggest opportunity fueling the technology sector. Underneath the AI umbrella, …
Read MoreBills proposing Social Security changes aren't unusual in Congress. With the program less than a decade from potential insolvency, those in government are …
Read MoreExplore the exciting world of CrowdStrike (NASDAQ: CRWD) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain …
Read MoreLast Friday, Donald Trump announced the launch of his new cryptocurrency, Official Trump (CRYPTO: TRUMP). The meme coin has gotten off to an explosive start. …
Read MoreIn this video, Motley Fool contributor Jason Hall explains why Dollar General‘s (NYSE: DG) turnaround represents a great profit opportunity, if not a …
Read MoreIt's normal to make more than a few flubs while investing, especially when you're new. At the same time, we owe it to ourselves to be humble and to recognize …
Read MoreCostco (NASDAQ: COST) boasts a membership renewal rate of over 90%. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the …
Read More